Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compare / Semaglutide vs Retatrutide

Semaglutide vs Retatrutide

Semaglutide is approved and widely prescribed. Retatrutide is still experimental. How they differ, and why their trial results cannot be lined up directly.

Side-by-side facts · No recommendation · Reviewed

SemaglutideRetatrutideSame for both

SemaglutideRetatrutide
Acts onGLP-1 receptorGIP, GLP-1 and glucagon receptors
StatusFDA-approved (Ozempic, Wegovy, Rybelsus)Investigational, not approved anywhere
Legitimate supplyPrescriptionNone outside clinical trials
FormsWeekly injection; daily tabletsWeekly injection in trials
EvidenceLarge published trials, including a head-to-head trial against liraglutidePhase 3 results announced in 2026, not yet peer-reviewed

Why the numbers are not comparable

No trial has compared the two directly. In the STEP 8 trial, average weight loss with semaglutide was 15.8% at 68 weeks. Retatrutide’s phase 3 trials reported up to 22.6% at 80 weeks in one trial.

Different trials enroll different people, run for different lengths of time and measure in different ways, so these figures cannot be set side by side as if they came from one study. Retatrutide’s full results have not yet been published in a peer-reviewed journal or reviewed by FDA.

Side effects

Both cause mainly stomach and bowel side effects. Semaglutide’s label carries a boxed warning about thyroid C-cell tumors seen in rodents. In retatrutide trials, 13.5% of people on the highest dose stopped because of side effects, compared with 4.8% on placebo, and trials also recorded altered skin sensation.

Availability

Semaglutide is available on prescription. Retatrutide is not legitimately available to patients anywhere. Anything sold online as retatrutide comes from outside the approved supply chain, with no assurance of identity, strength or sterility.

Questions

Is retatrutide stronger than semaglutide?

No head-to-head trial exists, and retatrutide’s results are not yet peer-reviewed or reviewed by FDA, so that cannot be answered yet.

Can retatrutide be prescribed?

No. It is investigational and not approved anywhere. It is available only inside clinical trials.

Is retatrutide sold online real?

There is no approved product. Products sold online have no assurance of identity, strength or sterility.

Which compound, if any, suits a person is a decision for them and a licensed prescriber. This page compares published facts and does not recommend either.

Sources: JAMA: STEP 8 trial (Rubino et al., 2022); Eli Lilly: TRIUMPH-2 and TRIUMPH-3 results; HCPLive: retatrutide phase 3 endpoints; Managed Healthcare Executive: GLP-1 pills; Prime Therapeutics: GLP-1 pipeline update, August 2026; Novo Nordisk: Wegovy and Saxenda safety information; Polsinelli: FDA compounded GLP-1 policy.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.